Intro

This chapter focuses on neuromuscular junction disorders, with a particular emphasis on myasthenia gravis. It discusses the antibody-mediated mechanism affecting acetylcholine receptors and describes the clinical symptoms, including fatigable weakness and the differences between ocular and generalized forms.